These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29530457)

  • 1. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness Outcomes in Patients With Recurrent or Refractory Head and Neck Cancers: Retrospective Analysis of Data From a Community Oncology Database.
    Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
    Clin Ther; 2018 Sep; 40(9):1522-1537. PubMed ID: 30150077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
    Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
    J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
    Ambrosio A; Jeffery DD; Hopkins L; Burke HB
    Mil Med; 2019 May; 184(5-6):e400-e407. PubMed ID: 30295883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions.
    Pang J; Crawford K; Faraji F; Ramsey C; Kemp A; Califano JA
    Otolaryngol Head Neck Surg; 2020 Sep; 163(3):546-553. PubMed ID: 32450778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
    Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
    J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
    Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
    Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non-Small Cell Lung Cancer at US Community Oncology Practices.
    Buck PO; Saverno KR; Miller PJ; Arondekar B; Walker MS
    Clin Lung Cancer; 2015 Nov; 16(6):486-95. PubMed ID: 25681298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
    Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
    J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents.
    Abraham P; Kish JK; Korytowsky B; Radtchenko J; Singh P; Shaw J; Feinberg B
    J Med Econ; 2020 Feb; 23(2):125-131. PubMed ID: 31581922
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
    Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
    Genther DJ; Gourin CG
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental health comorbidities and cost/utilization outcomes in head and neck cancer patients.
    Jeffery DD; Art Ambrosio L; Hopkins L; Burke HB
    J Psychosoc Oncol; 2019; 37(3):301-318. PubMed ID: 30882286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study.
    Adjei Boakye E; Johnston KJ; Moulin TA; Buchanan PM; Hinyard L; Tobo BB; Massa ST; Osazuwa-Peters N
    Am J Clin Oncol; 2019 Feb; 42(2):172-178. PubMed ID: 30300170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of head and neck cancer: a systematic literature review.
    Wissinger E; Griebsch I; Lungershausen J; Foster T; Pashos CL
    Pharmacoeconomics; 2014 Sep; 32(9):865-82. PubMed ID: 24842794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
    Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.